We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our
Cookie Policy
.
Accept
Label
Search
SKIP TO CONTENT
SKIP NAVIGATION
Drug News
Trending
Commercial Operations
GMPs
FDA Enforcement Actions
Inspections and Audits
Postmarket Safety
Quality
Regulatory Affairs
Research and Development
Submissions and Approvals
FDAnews Drug Weekly
FDAnews
Device News
Trending
Commercial Operations
FDA Enforcement Actions
Inspections and Audits
Postmarket Safety
Quality
Regulatory Affairs
Research and Development
Submissions and Approvals
FDAnews Device Weekly
FDAnews
Books
FDAnews Books Library
Drug Books
Device Books
Training/Events
Webinar Training Pass
Events
Webinar Recordings
Resources
Form 483s Database
FDA Approved Drugs
CenterWatch
About Us
The Company
FDAnews Editorial Board
Contact Us
Sign In
Create Account
Sign Out
My Account
Home
»
Store
» Generic Line
Search the Store
Shop By Category
Drug Products
Drug Books
Device Products
Device Books
Clinical Products
Shop By Media
Books
Webinar Recordings
Generic Line
-- Sort By --
New Arrivals
Best Sellers
Price: Low to High
Price: High to Low
A to Z
New Forum Aims to Promote Biosimilars Policy, Access
Price:
$40.00
Learn More
EGA Calls on EC to Push Generic, Biosimilar Exports
Price:
$40.00
Learn More
Pace of Generic Preapproval Audits Increasing, but More Must Be Done
Price:
$40.00
Learn More
Still Chasing Mylan, Teva Acquires Auspex
Price:
$40.00
Learn More
Mylan’s Generic Seasonale Oral Contraceptive Launches in U.S.
Price:
$40.00
Learn More
FDA Authorized in Approving Generic Abilify, Court Says
Price:
$40.00
Learn More
FDA Finalizes Biosimilars Guidance, Continues to Stress ‘Stepwise’ Approach
Price:
$40.00
Learn More
California Supreme Court Rules Against Pay to Delay in Cipro Case
Price:
$40.00
Learn More
FDA Approves Generic Abilify, Over Otsuka’s Objections
Price:
$40.00
Learn More
EMA Looking to Facilitate Generic Topical Approval
Price:
$40.00
Learn More
FDA Seeks Input from Drugmakers Ahead of GDUFA Reauthorization
Price:
$40.00
Learn More
AbbVie, Teva Face Pay-for-Delay Lawsuit Over Generic Niaspan
Price:
$40.00
Learn More
Previous
1
2
…
11
12
13
14
15
16
17
18
19
20
21
22
Next